Debt - Additional Information (Details)			3 Months Ended
	Mar. 24, 2025 USD ($) shares	Aug. 09, 2022 USD ($) $ / shares shares	Mar. 31, 2025 USD ($) shares	Mar. 31, 2024 USD ($)	Feb. 26, 2025 USD ($) offering	Dec. 31, 2024 USD ($) shares
Debt Instrument [Line Items]
Number Of Equity Offerings | offering					2
Repayments of long-term debt			$ 20,000,000	$ 0
Exchange agreement, principal amount of debt exchanged for securities (in shares)	$ 37,232.83
Amortization of debt issuance costs and debt discount			4,874,000	$ 1,559,000
Private Placement
Debt Instrument [Line Items]
Gain on loan forgiveness			600,000
Exchange agreement, principal amount of debt exchanged for securities (in shares)	$ 4,100,000
Exchange Agreement, units without warrants
Debt Instrument [Line Items]
Exchange agreement warrants acquired in agreement (in shares) | shares	3,723,283
Exchange Agreement, units without warrants | Common Warrants
Debt Instrument [Line Items]
Number of securities called by warrants or rights (in shares) | shares	7,446,562
Exchange Agreement, units without warrants | Certain convertible debt lenders | Common Warrants
Debt Instrument [Line Items]
Number of securities called by warrants or rights (in shares) | shares	1,861,642
Convertible Notes
Debt Instrument [Line Items]
Amortization period of debt discount (in years)		5 years
Remaining amortization period of debt discount (in years)		2 years 4 months 9 days
Facility Agreement
Debt Instrument [Line Items]
Debt issuance costs		$ 4,924,000
Facility Agreement | Convertible Notes
Debt Instrument [Line Items]
Debt instrument, face amount		$ 110,000,000			$ 20,000,000
Interest rate (as a percent)		4.00%
Minimum unrestricted cash and cash equivalent balance					$ 40,000
Repayments of long-term debt			20,000,000
Gain on loan forgiveness			$ 2,900,000
Debt instrument, convertible, conversion price (in dollars per share) | $ / shares		$ 8.567
Conversion cap (in shares) | shares		14,663,019
Conversion of stock, shares issued (in shares) | shares			0
Number of warrants outstanding (in shares) | shares			11,494,684			12,839,967
Proceeds from secured lines of credit		$ 110,000,000
Long-term debt			$ 73,894,000			$ 93,131,000
Debt issuance costs		$ 3,663,000	$ 1,586,000			2,211,000
Amortization period of debt issuance cost (in years)		5 years
Effective yield (as a percent)			10.64%	13.38%
Amortization of debt issuance costs and debt discount			$ 4,874,000	$ 1,559,000
Interest accrued			1,015,000	1,100,000
Accrued interest			$ 849,000	$ 1,100,000		$ 1,136,000
Facility Agreement | Convertible Notes | Covenant period one
Debt Instrument [Line Items]
Minimum net quarterly revenues		$ 75,000,000
Facility Agreement | Convertible Notes | Covenant period two
Debt Instrument [Line Items]
Minimum net quarterly revenues		100,000,000
Facility Agreement | Convertible Note Warrant
Debt Instrument [Line Items]
Long-term debt		0
Debt issuance costs		0
Facility Agreement | Optional Redemption
Debt Instrument [Line Items]
Long-term debt		0
Debt issuance costs		0
Facility Agreement | Embedded Conversion Option Feature
Debt Instrument [Line Items]
Long-term debt		28,160,000
Debt issuance costs		$ 1,261,000